Matches in Wikidata for { <http://www.wikidata.org/entity/Q73477207> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q73477207 description "article scientifique publié en 2000" @default.
- Q73477207 description "artículu científicu espublizáu en marzu de 2000" @default.
- Q73477207 description "im März 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73477207 description "scientific article published on 01 March 2000" @default.
- Q73477207 description "wetenschappelijk artikel" @default.
- Q73477207 description "wüsseschaftlicher Artikel, wo im März 2000 veröffentlicht worden isch" @default.
- Q73477207 description "наукова стаття, опублікована в березні 2000" @default.
- Q73477207 name "Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. The Valrubicin Study Group" @default.
- Q73477207 name "Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. The Valrubicin Study Group" @default.
- Q73477207 type Item @default.
- Q73477207 label "Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. The Valrubicin Study Group" @default.
- Q73477207 label "Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. The Valrubicin Study Group" @default.
- Q73477207 prefLabel "Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. The Valrubicin Study Group" @default.
- Q73477207 prefLabel "Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. The Valrubicin Study Group" @default.
- Q73477207 P1433 Q73477207-2E7FD7B4-EF5A-409B-846D-B7932F3EDBAC @default.
- Q73477207 P1476 Q73477207-D2474947-1A35-41C8-B8BC-59F790DA06E5 @default.
- Q73477207 P2093 Q73477207-06E8A04F-4D97-4164-83D5-9FC77162D379 @default.
- Q73477207 P2093 Q73477207-0A2FE0E5-A32C-4C6A-8346-FDA063F7864E @default.
- Q73477207 P2093 Q73477207-1E3EAB3F-BEB4-450B-807D-F5ECD93345E5 @default.
- Q73477207 P2093 Q73477207-2329FF8D-A7E7-4365-BFA1-F9A3068FEC52 @default.
- Q73477207 P2093 Q73477207-5E30F774-ED38-44D9-A1D6-0BD56AF67FA5 @default.
- Q73477207 P2093 Q73477207-E0118DED-A190-499D-8A66-6017F0663AE6 @default.
- Q73477207 P304 Q73477207-BC529BA5-B607-47D8-B454-9048314F2F91 @default.
- Q73477207 P31 Q73477207-3CDE115B-A708-4150-90C4-C4772A457412 @default.
- Q73477207 P356 Q73477207-B0ADFCA1-BE6F-4621-9228-ADA9B878D122 @default.
- Q73477207 P407 Q73477207-425C8FEF-9F93-448B-946E-FDBA2F26F8D3 @default.
- Q73477207 P433 Q73477207-116A2772-4B4C-4068-9C40-9520A2E415F7 @default.
- Q73477207 P478 Q73477207-4A48D5B7-268B-4969-9F19-282907A63EE9 @default.
- Q73477207 P577 Q73477207-8AADD9CE-5062-4519-8663-9D7B7E6ECE40 @default.
- Q73477207 P698 Q73477207-452721E1-5515-48AF-9D10-46A226F19A9F @default.
- Q73477207 P356 S0022-5347(05)67799-3 @default.
- Q73477207 P698 10687972 @default.
- Q73477207 P1433 Q15709979 @default.
- Q73477207 P1476 "Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. The Valrubicin Study Group" @default.
- Q73477207 P2093 "G Steinberg" @default.
- Q73477207 P2093 "M Wehle" @default.
- Q73477207 P2093 "R Bahnson" @default.
- Q73477207 P2093 "R Middleton" @default.
- Q73477207 P2093 "S Brosman" @default.
- Q73477207 P2093 "Z Wajsman" @default.
- Q73477207 P304 "761-767" @default.
- Q73477207 P31 Q13442814 @default.
- Q73477207 P356 "10.1016/S0022-5347(05)67799-3" @default.
- Q73477207 P407 Q1860 @default.
- Q73477207 P433 "3" @default.
- Q73477207 P478 "163" @default.
- Q73477207 P577 "2000-03-01T00:00:00Z" @default.
- Q73477207 P698 "10687972" @default.